MagVenture is proud to announce its partnership with Magnus Medical, providing its industry-leading MagPro® magnetic stimulation system to support an exciting new chapter in therapeutic transcranial magnetic stimulation (TMS) through Magnus’ SAINTⓇ  neuromodulation system.  SAINT therapy will enable patients to receive a quick, highly effective treatment for Major Depressive Disorder (MDD), especially in the acute setting where TMS has been limited in adoption.

MagVenture, celebrates a new milestone with the launch of MagVenture Pain Therapy—an FDA-cleared solution for chronic pain relief.

We are thrilled to announce our receipt of the esteemed His Royal Highness Crown Prince Frederik of Denmark’s International Business Award for Export Achievement. This recognition honors MagVenture Inc.’s strong determination to build a successful business in the US market since 2010.